Renaissance Technologies
NNVC icon

Renaissance Technologies’s NanoViricides NNVC Stock Holding History

Renaissance Technologies’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Sell
134,900
-38,503
-22% -$40.3K ﹤0.01% 3001
2025
Q4 		$196K Sell
173,403
-37,097
-18% -$52.1K ﹤0.01% 2889
2025
Q3 		$301K Buy
210,500
+99,100
+89% +$148K ﹤0.01% 2994
2025
Q2 		$156K Buy
111,400
+5,600
+5% +$7.65K ﹤0.01% 3214
2025
Q1 		$124K Sell
105,800
-39,900
-27% -$50.6K ﹤0.01% 3159
2024
Q4 		$208K Buy
145,700
+30,800
+27% +$44.2K ﹤0.01% 3160
2024
Q3 		$172K Buy
114,900
+12,800
+13% +$23.8K ﹤0.01% 3153
2024
Q2 		$176K Buy
102,100
+17,600
+21% +$31.3K ﹤0.01% 3073
2024
Q1 		$98K Buy
84,500
+6,000
+8% +$6.88K ﹤0.01% 3373
2023
Q4 		$80K Buy
78,500
+2,400
+3% +$2.77K ﹤0.01% 3360
2023
Q3 		$102K Sell
76,100
-2,500
-3% -$3.54K ﹤0.01% 3236
2023
Q2 		$90K Buy
78,600
+7,506
+11% +$9.07K ﹤0.01% 3501
2023
Q1 		$83K Sell
71,094
-5,879
-8% -$7.93K ﹤0.01% 3544
2022
Q4 		$85K Buy
76,973
+5,907
+8% +$9.21K ﹤0.01% 3670
2022
Q3 		$123K Buy
71,066
+11,066
+18% +$24.1K ﹤0.01% 3525
2022
Q2 		$113K Sell
60,000
-16,800
-22% -$30.9K ﹤0.01% 3815
2022
Q1 		$161K Buy
76,800
+32,200
+72% +$75.2K ﹤0.01% 3701
2021
Q4 		$166K Buy
+44,600
New +$203K ﹤0.01% 3576
2021
Q1 		– Sell
-75,613
Closed -$217K – 3584
2020
Q4 		$217K Buy
+75,613
New +$275K ﹤0.01% 3110
2020
Q1 		– Sell
-87,689
Closed -$220K – 3675
2019
Q4 		$220K Buy
87,689
+29,848
+52% +$67.5K ﹤0.01% 3170
2019
Q3 		$119K Buy
57,841
+4,026
+7% +$17.6K ﹤0.01% 3241
2019
Q2 		$258K Buy
53,815
+3,801
+8% +$19.5K ﹤0.01% 3233
2019
Q1 		$270K Buy
50,014
+4,356
+10% +$28.4K ﹤0.01% 3128
2018
Q4 		$183K Sell
45,658
-1,640
-3% -$10.5K ﹤0.01% 3153
2018
Q3 		$341K Buy
47,298
+2,879
+6% +$22.2K ﹤0.01% 2976
2018
Q2 		$391K Buy
44,419
+17,844
+67% +$219K ﹤0.01% 2905
2018
Q1 		$437K Buy
26,575
+2,045
+8% +$37.8K ﹤0.01% 2960
2017
Q4 		$432K Buy
24,530
+280
+1% +$5.73K ﹤0.01% 2920
2017
Q3 		$553K Buy
24,250
+1,670
+7% +$44.8K ﹤0.01% 2767
2017
Q2 		$610K Buy
22,580
+2,170
+11% +$53.6K ﹤0.01% 2714
2017
Q1 		$457K Buy
20,410
+1,880
+10% +$43.8K ﹤0.01% 2793
2016
Q4 		$397K Buy
18,530
+1,315
+8% +$35.1K ﹤0.01% 2839
2016
Q3 		$582K Buy
17,215
+100
+0.6% +$3.31K ﹤0.01% 2766
2016
Q2 		$548K Buy
17,115
+3,190
+23% +$116K ﹤0.01% 2764
2016
Q1 		$610K Buy
13,925
+6,575
+89% +$255K ﹤0.01% 2784
2015
Q4 		$173K Buy
7,350
+1,870
+34% +$44.8K ﹤0.01% 3031
2015
Q3 		$130K Sell
5,480
-5,563
-50% -$147K ﹤0.01% 2973
2015
Q2 		$382K Buy
11,043
+9,418
+580% +$359K ﹤0.01% 2801
2015
Q1 		$73K Buy
1,625
+701
+76% +$37.4K ﹤0.01% 3044
2014
Q4 		$50K Buy
+924
New +$61.2K ﹤0.01% 2877

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $91.3M AUM 21.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies's NNVC Position: Q1 2026 in Review

Renaissance Technologies reduced its NanoViricides (NNVC) stake by 22% in Q1 2026, selling an estimated $40.3K and leaving 134,900 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3001.

Renaissance Technologies first reported a position in NNVC in Q4 2014 and has held it in 40 quarters since. The position peaked at $610K in Q2 2017. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • Renaissance Technologies held 134,900 shares of NanoViricides worth $123K as of Q1 2026.
  • Renaissance Technologies sold 38,503 NanoViricides shares in Q1 2026, an estimated $40.3K.
  • NanoViricides made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3001 holding.
  • Renaissance Technologies first reported a position in NanoViricides in Q4 2014 and has held it in 40 quarters since.
  • Renaissance Technologies's NanoViricides position peaked at $610K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.